Tetrazole

Tetrazole

SCHEMBL1012000

Cl.O.c1nnn[nH]1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Tetrazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrazole SCHEMBL29614407 0.97
Tetrazole SCHEMBL29044817 0.97
Tetrazole SCHEMBL29079509 0.97
Tetrazole SCHEMBL3245869 0.97
Tetrazole SCHEMBL21856 0.97
Tetrazole SCHEMBL6130450 0.97
Tetrazole SCHEMBL4257957 0.97
Tetrazole SCHEMBL916470 0.97
Tetrazole SCHEMBL6130451 0.97
Tetrazole SCHEMBL27304960 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6379587-B1 MIXTURE OF NITRO BLUE TETRAZOLIUM AND POLYMALEIC ACID BETZDEARBORN INC. 2002-04-30 US claimed
US-12042986-B2 3-dimensional printed parts HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2024-07-23 US disclosed
US-12011874-B2 Strain sensors HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2024-06-18 US disclosed
US-20240158657-A1 BIOCIDE COMPOSITION HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2024-05-16 US disclosed
US-20230347587-A1 3-D PRINTING PERIDOT PRINT LLC 2023-11-02 US disclosed
US-20230348741-A1 COMPOSITE PARTICULATE BUILD MATERIALS PERIDOT PRINT LLC 2023-11-02 US disclosed
US-20230303884-A1 PRETREAT COMPOSITIONS PERIDOT PRINT LLC 2023-09-28 US disclosed
US-11745417-B2 Three-dimensional printing HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2023-09-05 US disclosed
US-11732150-B2 Composite particulate build materials HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2023-08-22 US disclosed
CN-112055647-B Three-dimensional printing 惠普发展公司,有限责任合伙企业 2023-08-11 CN disclosed
EP-1024182-A1 Ink compositions having superior smearfastness and reduced smudging and blot dry time Hewlett-Packard Company (US) 2000-08-02 EP disclosed
US-6057384-A VEHICLE AND COLORANT ASSOCIATED WITH A PRIMER CORE/SHELL POLYMER; DURABLR SMEAR-FAST FILM HEWLETT-PACKARD COMPANY (US) 2000-05-02 US disclosed
US-6036759-A Black to color bleed control in ink-jet printing inks HEWLETT-PACKARD COMPANY (US) 2000-03-14 US disclosed
WO-2000011239-A1 INHIBITION OF CORROSION IN AQUEOUS SYSTEMS BETZDEARBORN INC. (US) 2000-03-02 WO disclosed
US-6019828-A Ink compositions having superior smearfastness and reduced smudging and blot dry time HEWLETT-PACKARD COMPANY (US) 2000-02-01 US disclosed
US-5990202-A DURABLE, SMEAR-FAST INK FILMS COMPRISING DUAL ENCAPSULATED COLORANT; A PRIMER CORE/SHELL POLYMER COATING A COLORANT (ADHESION) AND AN EXTERIOR CORE/SHELL POLYMER COATING FOR DURABILITY HEWLETT-PACKARD COMPANY (US) 1999-11-23 US disclosed
WO-1999023181-A1 INK-JET INK COMPOSITIONS HAVING MAGNETIC PROPERTIES HEWLETT-PACKARD COMPANY (US) 1999-05-14 WO disclosed
WO-1999023182-A1 LATEX POLYMER BLENDS FOR INK-JET INKS HEWLETT-PACKARD COMPANY (US) 1999-05-14 WO disclosed
WO-1999023183-A1 PRINTING INK COMPOSITIONS HAVING SUPERIOR SMEAR-FASTNESS HEWLETT-PACKARD COMPANY (US) 1999-05-14 WO disclosed
US-5457089-A Treating renal anemia BEHRINGWERKE AKTIENGESELLSCHAFT (DE) 1995-10-10 US disclosed